How Much Upside is Left in Halozyme Therapeutics (HALO)? Wall Street Analysts Think 27.08%
Portfolio Pulse from
Wall Street analysts suggest a potential 27.1% upside for Halozyme Therapeutics (HALO) based on average price targets. Positive earnings estimate revisions could support this potential increase.
December 16, 2024 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wall Street analysts have set an average price target for Halozyme Therapeutics (HALO) indicating a potential upside of 27.1%. This is supported by positive trends in earnings estimate revisions.
The article highlights a significant potential upside for HALO based on analyst price targets and positive earnings estimate revisions. This suggests a bullish sentiment among analysts, which could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100